Showing results (181-190 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|September 15, 2015
Increased CD38 expression on T lymphocytes as a marker of HIV dissemination into the central nervous systemChiara Dentone, Daniela Fenoglio, Eva Schenone, et al.
HIV Clinical Trials|April 15, 2016
Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 studyIsabelle Poizot-Martin, Eric Bellissant, Rodolphe Garraffo, et al.
HIV Clinical Trials|April 25, 2018
A multi-site community randomized trial of community health workers to provide counseling and support for patients newly entering HIV care in rural Ethiopia: study design and baseline implementationAlan R Lifson, Sale Workneh, Abera Hailemichael, et al.
HIV Clinical Trials|February 3, 2006
Higher virological effectiveness of NNRTI-based antiretroviral regimens containing nevirapine or efavirenz compared to a triple NRTI regimen as initial therapy in HIV-1-infected adultsMaría Jesús Pérez-Elías, Ana Moreno, Santiago Moreno, et al.
HIV Clinical Trials|February 3, 2006
Changes in body fat measured by DEXA in patients taking different formulations of stavudineYong Yang, Annelies Wilder-Smith, Anushia Panchalingam, et al.
HIV Clinical Trials|April 20, 2010
Degree of viral decline early in treatment predicts sustained virological response in HCV-HIV coinfected patients treated with peginterferon alfa-2a and ribavirinM Rodriguez-Torres, F Torriani, J Rockstroh, et al.
HIV Clinical Trials|June 3, 2009
Evolution of hematological parameters in HIV-1-infected patients with and without thalassemia carriages during highly active antiretroviral therapySakorn Pornprasert, Pakhaporn Sonboon, Suchart Kiatwattanacharoen, et al.
HIV Clinical Trials|April 14, 2009
Effects of first-line use of nucleoside analogues, efavirenz, and ritonavir-boosted protease inhibitors on lipid levelsAndrew Hill, Will Sawyer, Brian Gazzard
HIV Clinical Trials|April 14, 2009
Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documentsAndrea L Ciaranello, Rochelle P Walensky, Paul E Sax, et al.
HIV Clinical Trials|April 14, 2009
Rates of HCV treatment eligibility among HCV-monoinfected and HCV/HIV-coinfected patients in tertiary care referral centersAdeel A Butt, Uzma A Khan, Obaid S Shaikh, et al.
Pageof 68